Pfizer confronts ‘peak of anti-vaccination rhetoric’ as shares rebound By: MarketWatch October 16, 2023 at 11:05 AM EDT Cost-saving program "will touch all parts of the business" but won't affect Seagen acquisition, Pfizer says. Read More >> Related Stocks: Moderna, Inc. - Common Stock Pfizer Seagen Inc. - Common Stock
